If WHO continue down this path, then can we assume Gilead will be encouraged to find an improved Remdesivir product like our DEP Remdesivir ?
https://www.cnbc.com/2020/11/19/cor...se-gileads-remdesivir-splitting-with-fda.html
WHO tells doctors not to use Gilead’s remdesivir as a coronavirus treatment, splitting with FDA
- A WHO panel advised doctors against using Gilead Sciences’ antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19.
- The group said there is currently “no evidence” that it improves survival rates or the need for ventilation.
- The recommendation was published in the British medical trade journal The BMJ on Friday in the EU.
- Forums
- ASX - By Stock
- SPL
- Ann: AGM Chairman address and CEO presentation
Ann: AGM Chairman address and CEO presentation, page-18
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.39M |
Open | High | Low | Value | Volume |
9.2¢ | 9.3¢ | 9.1¢ | $285.5K | 3.101M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 548218 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 95900 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 548218 | 0.092 |
2 | 71451 | 0.091 |
7 | 98853 | 0.090 |
2 | 86179 | 0.089 |
2 | 45464 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 95900 | 2 |
0.094 | 69440 | 2 |
0.095 | 182403 | 3 |
0.096 | 104177 | 1 |
0.098 | 11506 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online